Navigation Links
Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc.
Date:5/9/2013

NEWARK, N.J., May 9, 2013 /PRNewswire/ -- Sanford Heisler LLP today filed a $100 million individual and class action suit in the U.S. District Court for New Jersey against pharmaceutical giant Merck & Co., Inc.

The action was brought by Kelli Smith on behalf of all female sales representatives at Merck.  The complaint asserts that the company systematically discriminates against its female and pregnant employees in assignment, promotion, advancement, and pay and retaliates against female employees in violation of Title VII of the US Civil Rights Act, the Lilly Ledbetter Fair Pay Act, the Family and Medical Leave Act and the New Jersey Law Against Discrimination.

"Merck is a male-dominated workplace openly hostile to the success and advancement of women," said David Sanford , Founder and Chairman of Sanford Heisler and lead attorney on Ms. Smith's legal team.  "Its discrimination against mothers is particularly egregious because Merck's compensation structure decreases the pay of managers whose subordinates take maternity leave." 

Other members of Ms. Smith's legal team include Kate Mueting , an associate in Washington, D.C, and Deborah Marcuse, a Senior Litigation Counsel in New York. Sanford Heisler LLP has a long record of victories in employment discrimination matters brought by female employees of global pharmaceutical companies, including a recent case against Novartis that resulted in the largest ever monetary award in a U.S. employment discrimination case.

Ms. Smith's suit details a widespread pattern of employment discrimination. Merck discourages management from hiring and promoting women, attempts to force pregnant women to leave the company so their managers' compensation will n
'/>"/>

SOURCE Sanford Heisler LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action In Southern District Of New York
2. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
3. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
4. Concord Medical Files 2012 Annual Report on Form 20-F with U.S. Securities and Exchange Commission
5. Sinovac Files Annual Report on Form 20-F
6. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
7. Update to Shareholders on Dividend Payment: Medisafe 1 Technologies Corporation Files Corporate Action Form with FINRA for the Dividend Distribution to its Shareholders
8. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
9. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
10. Receptos Files Registration Statement for Proposed Initial Public Offering
11. VolitionRx Files Two Patent Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Mich. , Sept. 19, 2014  Diplomat, the ... of David Dreyer to the Board of ... independent director and will also serve as chair of ... almost 30 years of accounting, financial, compliance and operating ... Mr. Dreyer has served as chief financial officer, chief ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... 2014 Five MinuteClinic walk-in medical clinics are opening inside ... area. Three clinics opened in Memphis and ... will be added in Springfield on September ... is expected to open October 22.  MinuteClinic is the largest and ... United States . The Memphis ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... , , , , , , , , , ... and LAUSANNE, Switzerland , February 4 ... Debiopharm Group (Debiopharm), a Swiss-based global,biopharmaceutical group of companies with ... medical needs, announce the launch by,Ipsen in France ...
... , REDWOOD CITY, Calif. , Feb. ... financial results for the year ended December 31, 2009 , which ... cash flow positive. , Total revenue for the fourth quarter of 2009 ... in the fourth quarter of 2008.  Product revenue from the Onco type ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
(Date:9/19/2014)... 19, 2014 Follow us on ... the medical imaging market, are engineered to enhance the ... the past three decades have expanded the application roles ... iodine based agents used for over half a century ... imaging agents have witnessed sea changes, revolutionizing in the ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 ... ligand assays used for detection and quantification of ... given sample. Driven by steady expansion in immunodiagnostics ... the global immunoassay systems market has evolved remarkably ... conditions, such as diabetes, cardio-vascular ailments, infectious diseases, ...
(Date:9/19/2014)... September 19, 2014 The ... traditional Scandinavian style of eating, is making ... like Diet Doc’s medical weight loss ... and eating good food which leads to ... on teaching patients to understand how diet ...
(Date:9/19/2014)... September 19, 2014 The Relaxation ... years to 2014. Industry operators were able to mass ... period, as well as establish distribution contracts with nation-wide ... large part to its novelty; energy drinks have only ... time, industry operators have been able to establish brands ...
(Date:9/19/2014)... 19, 2014 Recent financial data ... industry increased their sales by 7% in the last ... trucking industry can be used as a bellwether to ... whole. This data has been proven to show trends ... freight transportation. Other non-trucking data is largely influenced by ...
Breaking Medicine News(10 mins):Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 2Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 3Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 2Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 3
... If war is too serious a matter to be left in ... be left to the care of labour department officials. At least ... ,Latest trends show that agencies like the Occupational Safety and ... of the industries than with the safety of the workers themselves. ...
... Despite being safe, anti-anginal medication Ranolazine has not been ... such as death// , heart attack or recurrent ischemia ... the treatment of acute coronary syndromes (ACS), the risk ... used for patients with chronic angina, but because of ...
... the body’s genetic repair system may cause Huntington’s disease, ... destroying their nervous system. Until now, no one knew ... ,"We showed that when single-strand breaks in DNA ... continued to add extra replacement segments," explains Cynthia McMurray, ...
... Center have zeroed in on a crucial gene, thought ... cancer and resistance// to long-term estrogen deprivation. The gene ... breast cancer reappearance, and would enable a good idea ... ,The research targeted breast cancer cells which had ...
... sentence is being questioned. A study by Plos medicine reveal that ... by the UK based Lancet in 2005. ,This injection ... federal government but many have put a stop to it as ... one drug to induce sleep, the second to stop breathing and ...
... die due to cancer every day, Health Minister Anbumani Ramadoss ... cases in the country were due to tobacco consumption. ... are due to tobacco. The relationship between oral cancer and ... which 91 percent of oral cancers in Southeast Asia are ...
Cached Medicine News:Health News:Overseeing Agency Indifferent to Workplace Safety in US 2Health News:Anti-anginal Drug Not Effective in Reducing Major Cardiac Events 2Health News:Researchers Discovers DNA Repair as Key to Huntington's Disease 2Health News:Execution by Lethal Injection Questioned 2
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Open 11 mm blades. Dull finish. Most popular size or model....
Open 15 mm blades with lifting wings manipulation of I/A cannulas, knives, instrumentation, etc. Screwlocking mechanism. Dull finish....
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Medicine Products: